Functional studies showed that Sox17 overexpression in tECs drove aberrant tumor angiogenesis, whereas knockdown significantly delayed tumor progression by inhibiting pathological neovascularization and promoting vascular remodeling. Here, SOX17 is linked to neoplasm.